No Data
No Data
Beijing Tongrentang (600085.SH) announced a semi-annual equity distribution for 2024: a dividend of 0.50 yuan per share, with a record date of October 9.
Beijing Tongrentang (600085.SH) released the semi-annual equity distribution announcement for 2024, this profit distribution is implemented in the following scheme...
China Merchants Securities: Profit performance is better than revenue, and top OTC brands have stronger resilience.
In the first half of 2024, high-end scarce resources and traditional Chinese medicine OTC enterprises with brand and channel barriers performed well, while hospital-based traditional Chinese medicine enterprises were under short-term pressure due to industry policies and other factors.
Deutsche Bank: Maintains a "shareholding" rating for tongrentangcm (03613), with a target price lowered to HKD 12.8.
Daiwa has revised down its profit forecast for Tongrentangcm (03613) for the years 2024-2030 by 6%-10%.
[Brokerage Focus] China Securities Co.,Ltd. (03613) maintains a "buy" rating for Tongrentangcm, indicating that overall performance is expected to gradually recover.
China Securities Co., Ltd. issued a research report, stating that Tongrentangcm (03613) achieved revenue of 0.665 billion Hong Kong dollars in the first half of 2024, a year-on-year decrease of 18.2%, and a net income of 0.22 billion Hong Kong dollars, a year-on-year decrease of 17.4%. The company's performance is under short-term pressure, mainly due to weak retail markets in Hong Kong and Macau, weak consumer spending power of residents and tourists, and a significant decline in sales revenue. In the second half of the year, with the gradual improvement of the consumption environment in Hong Kong, stable growth in overseas markets, and continuous volume growth in the mainland market, the overall performance is expected to gradually recover. The bank is bullish on the steady recovery of the company's operation in the second half of the year.
tongrentangcm (03613) fell 25.50%, now at 7.340 yuan, hitting a 52-week low.
As of 11:47, Tongrentangcm (03613) dropped 25.50% compared to the previous closing price, currently trading at 7.340 yuan, a new 52-week low; the volume was 1.297 million shares, with a turnover of 9.5201 million Hong Kong dollars.
The operation is fundamentally stable, and tong ren tang Technology (01666.HK) has entered a period of development dividends.
The concept of traditional Chinese medicine stocks in the Hong Kong stock market is a relatively "alternative" branch in the overall performance of the pharmaceutical sector in recent years. Looking at its underlying logic, on the one hand, it is due to the frequent blowing of favorable policies, which continuously brings bullish news to the traditional Chinese medicine industry and stimulates the performance of the capital markets. On the other hand, it is also due to the relatively lower valuations in this field compared to other subdivisions of the pharmaceutical industry. At the same time, the performance growth of traditional Chinese medicine companies, which are more consumer-oriented, has been quite strong, continuously boosting market confidence. Based on this, the traditional Chinese medicine sector has become one of the few sectors in the market that can withstand cyclical fluctuations. In recent years, the scale of the traditional Chinese medicine industry has continued to grow.
No Data
No Data